click below
click below
Normal Size Small Size show me how
PHARMA BLOOD
| Question | Answer |
|---|---|
| A condition of chronic excess total body iron caused either by an inherited abnormality of iron absorption or by frequent transfusions to treat certain types of hemolytic disorders | Hemochromatosis |
| A deficiency in serum hemoglobin and erythrocytes in which the erythrocytes are abnormally large . Results from either folate or vitamin B12 deficiency anemia | Megaloblastic anemia |
| A deficiency in serum hemoglobin and erythrocytes in which the erythrocytes are abnormally small . Often caused by iron deficiency | Microcytic anemia |
| An abnormally low number of neutrophils in the blood; patients with neutropenia are susceptible to serious infection | Neutropenia |
| most common type of megaloblastic anemia resulting from deficiency of intrinsic factor, a protein produced by gastric mucosal cells and required for intestinal absorption of vitamin B12 | Pernicious anemia |
| An abnormally low number of platelets in the blood; patients with thrombocytopenia are susceptible to hemorrhage | Thrombocytopenia |
| Required for the biosynthesis of heme and heme-containing proteins , including hemoglobin and myoglobin Uses: iron deficiency anemia | Ferrous Sulfate |
| Chelates excess iron (If the patient has acute iron intoxication Uses: acute iron poisoning , hemachromatosis not adequately treated with phlebotomy | Deferoxamine |
| Cofactor in the transfer of 1-carbon units, a step necessary for the synthesis of DNA Cobalt-containing molecule Produced only by bacteria 2 forms: cyanocobalamin, hydroxocobalamin | Vitamin B12 |
| Required for normal DNA synthesis Deficiency during pregnancy increases the risk of neural defects in the fetus | Folic Acid |
| Agonist of erythropoietin receptors expressed by red cell progenitors Uses: anemia associated with chronic renal failure , HIV infection, cancer, and prematurity | Epoetin Alfa |
| A granulocyte colony stimulating factor Accelerates neutrophil recovery and reduces incidence of infection USES: neutropenia assoc. w/ chemotherapy, myelodysplasia, and aplastic anemia, | Filgrastim |
| To regulate the differentiation and maturation of stem cells within the bone marrow Stimulate the bone marrow to produce specific blood cells & help its formation, maturation and function | Hematopoic Growth Factors - |
| DRUGS USED IN COAGULATION DISORDER platelet activator and powerful vasoconstrictor | Thromboxane A2 |
| DRUGS USED IN COAGULATION DISORDER a potent endothelium derived vasoconstrictor | Endothelin |
| DRUGS USED IN COAGULATION DISORDER platelet aggregation | Adenosine PO4 (ADP): |
| DRUGS USED IN COAGULATION DISORDER platelet aggregation and vasoconstriction | Serotonin: |
| is the most common cause of acute myocardial infarction, ischemic stroke and limb gangrene | Arterial thrombosis |
| Non-selective, irreversible COX 1 and 2 inhibitor Reduces platelet production of TXA2 , a potent stimulator of platelet aggregation Uses: prevention of arterial thrombosis, inflammatory disorders | aspirin |
| Inhibits Platelet Aggregation By Interfering With (glycoproteinIIb/IIIareceptor) GPIIb/IIIa binding to fibrinogen and other ligands | Abciximab |
| Irreversibly inhibits binding of ADP to platelet receptors , reducing platelet aggregation | Clopidogrel |
| Inhibits phosphodiesterase III and increased cAMP in platelets and blood vessels Inhibits platelet aggregation and causes vasodilation | Dipyridamole |
| Mainly for the prevention and treatment of venous thrombosis (pulmunary embolism & deep vein thrombosis Drugs that inhibits formation of fibrin clots | Anticoagulants |
| also called thrombolytics medications that dissolve blood clots for myocardial infarction, ischemic stroke, or massive pulmunary embolism Converts plasminogen to plasmin | Fibrinolytic drugs |
| Inhibits plasmin and plasmin-streptokinase complex in patients who have received streptokinase | Aprotonin |